FH FOLR1 ST CAR T-cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Anti-FOLR1 CAR-T Cells, FH-FOLR1 CAR T Cells

Filter by location:

Seattle, Washington1 trial

Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial

Fred Hutch/University of Washington/Seattle Children's Cancer Consortium

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.